Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
World J Clin Cases ; 11(30): 7398-7402, 2023 Oct 26.
Article in English | MEDLINE | ID: mdl-37969457

ABSTRACT

BACKGROUND: Fournier gangrene is a rare, life-threatening infection characterized by necrotizing fasciitis in the perineal, genital and/or lower abdominal regions. Despite its rarity, the unfavorable prognosis associated with this disease is dependent on the timing of medical care. CASE SUMMARY: A 3-month-old boy was admitted to our pediatric intensive care unit in critical condition after a 5-day history of fever and scrotal erythema with breaching skin lesions and swelling. Despite ambulatory antibiotic treatment, the child's clinical condition deteriorated. At the time of admission, the child had necrotizing scrotal fasciitis that had spread to the abdomen. Following reanimation, the surgeon decided on an immediate intervention to rule out testicular torsion and to debride the affected area. Despite optimal antibiotic and supportive therapy, the patient developed severe sepsis with liver dysfunction, making treatment more challenging. CONCLUSION: Recognizing Fournier gangrene, prompt referral to pediatric surgery, and appropriate antibiotic coverage are critical for avoiding sepsis and multiorgan dysfunction.

2.
Curr Health Sci J ; 49(1): 134-138, 2023.
Article in English | MEDLINE | ID: mdl-37780198

ABSTRACT

Surfactant deficiency is a rare genetic disease. Clinical presentation is manifested with a large specter that varies from severe form to lethal in neonatal age and to progressive, chronic form of the interstitial lung disease in older child. In this manuscript we want to present the case of a two years and 7-month-old child, which was diagnosed with Pediatric Acute Respiratory Distress Syndrome (PARDS) as consequence of bilateral interstitial pneumonia. The child was treated in a supportive way, placed in mechanical ventilation, antibiotic therapy and corticosteroid. After the complete examination, the child resulted with surfactant metabolism dysfunction of type ABCA3. In this case we want to emphasize the attention for rare genetic disease like surfactant deficiency as a cause of recurrent pneumonia cases with unclear focus.

3.
Minerva Pediatr (Torino) ; 74(5): 568-578, 2022 Oct.
Article in English | MEDLINE | ID: mdl-35822579

ABSTRACT

Fever is an abnormal increase in body temperature that occurs as part of a specific biologic response mediated and controlled by the central nervous system. Despite the fact that most fevers are viral in origin, approaching a febrile child is always a concern for any physician. There is still a significant gap between current practice and scientific evidence. According to research, we are at a crossroad, with strong research evidence accumulating over the last few decades supporting a positive role for fever and the ongoing pressures of current practice to lower body temperature. Despite the fact that most pediatricians agree that treating a febrile child with antipyretics is primarily for the relief of fever symptoms, many continue to prescribe antipyretics for any child with fever, ignoring important research messages. By prescribing antipyretics to children who are only mildly febrile, pediatricians may contribute to fever phobia. We give parents the impression that fever is harmful and that antipyresis is beneficial when we focus on treating the fever. The purpose of this review is to present the evidence that is currently available regarding the management of the febrile child.


Subject(s)
Antipyretics , Child , Humans , Antipyretics/therapeutic use , Fever/therapy , Fever/diagnosis , Body Temperature , Pediatricians , Parents
4.
BMC Pediatr ; 22(1): 300, 2022 05 21.
Article in English | MEDLINE | ID: mdl-35597923

ABSTRACT

BACKGROUND: The majority of children with COVID-19 have only minor symptoms or none at all. COVID-19, on the other hand, can cause serious illness in some children, necessitating hospitalization, intensive care, and invasive ventilation. Many studies have revealed that SARS-CoV-2 affects not only the respiratory system, but also other vital organs in the body. We report here a child with an atraumatic splenic rupture as the initial and only manifestation of COVID-19. CASE PRESENTATION: A 13-year-old boy with clinical signs of acute abdomen, left-sided abdominal pain, and hemodynamic instability was admitted to the PICU in critical condition. His parents denied any trauma had occurred. In addition to imaging tests, a nasopharyngeal swab was taken for COVID-19 testing, which was positive. The thoracic CT scan was normal, whereas the abdominal CT scan revealed hemoperitoneum, splenic rupture, and free fluid in the abdomen. CONCLUSIONS: The spleen is one of the organs targeted by the SARS-CoV-2. Splenic rupture, a potentially fatal and uncommon complication of COVID-19, can be the first and only clinical manifestation of the disease in children. All pediatricians should be aware of the possibility of atraumatic splenic rupture in children with COVID-19.


Subject(s)
COVID-19 , Splenic Rupture , Adolescent , COVID-19/complications , COVID-19 Testing , Child , Humans , Male , SARS-CoV-2 , Splenic Rupture/diagnostic imaging , Splenic Rupture/etiology
5.
BMC Pediatr ; 19(1): 216, 2019 07 02.
Article in English | MEDLINE | ID: mdl-31266444

ABSTRACT

BACKGROUND: Propranolol hydrochloride is the first-line agent recommended for the treatment of infantile hemangiomas (IH). Serious adverse effects of propranolol therapy for hemangiomas are infrequent. CASE PRESENTATION: We report a case presented in deep hypoglycemic coma during his treatment with propranolol for IH. Through our case report and the review of the literature, we aimed to underline the importance of recognizing adverse effects during propranolol therapy. Although propranolol has a long history of safe and effective use in infants and children, pediatricians should be aware that life-threatening adverse effects can happen during propranolol therapy for IH. CONCLUSION: Early identification of these adverse effects can be of great importance for patient management and prognosis. It must certainly be noted that not just early identification among doctors, but education for parents is crucial.


Subject(s)
Adrenergic beta-Antagonists/adverse effects , Coma/chemically induced , Hemangioma/drug therapy , Hypoglycemia/chemically induced , Propranolol/adverse effects , Administration, Oral , Adrenergic beta-Antagonists/administration & dosage , Glucose/administration & dosage , Humans , Hypoglycemia/therapy , Infant , Male , Propranolol/administration & dosage
6.
J Pediatr Intensive Care ; 7(2): 110-114, 2018 Jun.
Article in English | MEDLINE | ID: mdl-31073482

ABSTRACT

A 1-month-old child was admitted at our pediatric intensive care unit (PICU) in a very critical state with generalized cyanosis, grunting, high fever, tachypnea, tachycardia, severe hypotension with capillary refill time > 5 seconds, and no palpable pulse. The child was apparently doing well until a few hours before admission. On admission to PICU, his clinical diagnosis was consistent with severe sepsis with his sequential organ failure assessment scores of 7 to 8 points. We started rapid restoration of circulation with aggressive volume replacement and empiric antimicrobial therapy. Despite optimal supportive therapy, the patient showed severe liver injury leading to liver failure, making the treatment more challenging. His simplex real-time reverse transcriptase polymerase chain reaction assay and enzyme linked immune sorbent assay documented respiratory syncytial virus (RSV) infection. Through our case report we would like to highlight the extrapulmonary manifestations of RSV infections and the importance of liver dysfunction during sepsis.

7.
BMC Infect Dis ; 17(1): 222, 2017 03 22.
Article in English | MEDLINE | ID: mdl-28330443

ABSTRACT

BACKGROUND: This multi-country prospective study of infants aged <1 year aims to assess the frequency of influenza virus and respiratory syncytial virus (RSV) infections associated with hospitalizations, to describe clinical features and antibody response to infection, and to examine predictors of very severe disease requiring intensive care. METHODS/DESIGN: We are enrolling a hospital-based cohort and a sample of non-ill infants in four countries (Albania, Jordan, Nicaragua, and the Philippines) using a common protocol. We are currently starting year 2 of a 2- to 3-year study and will enroll approximately 3,000 infants hospitalized for any acute illness (respiratory or non-respiratory) during periods of local influenza and/or RSV circulation. After informed consent and within 24 h of admission, we collect blood and respiratory specimens and conduct an interview to assess socio-demographic characteristics, medical history, and symptoms of acute illness (onset ≤10 days). Vital signs, interventions, and medications are documented daily through medical record abstraction. A follow-up health assessment and collection of convalescent blood occurs 3-5 weeks after enrollment. Influenza and RSV infection is confirmed by singleplex real time reverse transcriptase polymerase chain reaction (rRT-PCR) assays. Serologic conversion will be assessed comparing acute and convalescent sera using hemagglutination inhibition assay for influenza antibodies and enzyme-linked immunosorbent assay (ELISA) for RSV. Concurrent with hospital-based enrollment, respiratory specimens are also being collected (and tested by rRT-PCR) from approximately 1,400 non-ill infants aged <1 year during routine medical or preventive care. DISCUSSION: The Influenza and RSV in Infants Study (IRIS) promises to expand our knowledge of the frequency, clinical features, and antibody profiles of serious influenza and RSV disease among infants aged <1 year, quantify the proportion of infections that may be missed by traditional surveillance, and inform decisions about the potential value of existing and new vaccines and other prevention and treatment strategies.


Subject(s)
Hospitalization/statistics & numerical data , Influenza, Human/epidemiology , Respiratory Syncytial Virus Infections/epidemiology , Respiratory Syncytial Virus, Human/isolation & purification , Albania/epidemiology , Antibodies, Viral , Female , Humans , Infant , Influenza, Human/diagnosis , Jordan/epidemiology , Male , Nicaragua/epidemiology , Philippines/epidemiology , Prevalence , Prospective Studies , Real-Time Polymerase Chain Reaction , Respiratory Syncytial Virus Infections/diagnosis , Respiratory Syncytial Viruses , Risk Factors
9.
Ital J Pediatr ; 40: 35, 2014 Apr 04.
Article in English | MEDLINE | ID: mdl-24708654

ABSTRACT

Idiopathic pulmonary hemosiderosis is a rare disorder that can occur at any age and is characterized by the triad of hemoptysis, iron deficiency anemia and diffuse pulmonary infiltrates. The clinical course is exceedingly variable especially in children and a substantial proportion of this age group is undiagnosed. It is probably due to the fact that iron deficiency anemia may be the first and the only manifestation of IPH, preceding other symptoms and signs by several months and IPH is not considered as a rare cause of anemia, unless the typical triad is present. We present a case of IPH in a 13-year-old girl, treated for several months with persistent iron deficiency anemia, without response to therapy.


Subject(s)
Anemia, Iron-Deficiency/complications , Hemoglobins/metabolism , Hemosiderosis/diagnosis , Lung Diseases/diagnosis , Adolescent , Anemia, Iron-Deficiency/blood , Anemia, Iron-Deficiency/diagnosis , Diagnosis, Differential , Erythrocyte Count , Erythrocyte Indices , Female , Follow-Up Studies , Hemosiderosis/blood , Hemosiderosis/etiology , Humans , Iron/blood , Lung Diseases/blood , Lung Diseases/etiology , Tomography, X-Ray Computed , Hemosiderosis, Pulmonary
SELECTION OF CITATIONS
SEARCH DETAIL
...